Daclatasvir is an antiviral medication used in combination with sofosbuvir to treat chronic hepatitis C infections, specifically genotype 1 or 3. It functions as an NS5A inhibitor, blocking viral replication and reducing the viral load in the liver. This medication is critical for managing hepatitis C, a contagious infection that can lead to severe liver complications. In summary, Daclatasvir is essential for treating chronic hepatitis C infections.
Daclatasvir inhibits the NS5A protein of the hepatitis C virus, disrupting the viral replication process and reducing viral load.


